Exane Derivatives’s Cardinal Health CAH Stock Holding History

Exane Derivatives’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$418	Sell	8 -1	-11%	-$52	﹤0.01%	592
2022 Q1	$510	Sell	9 -1,401	-99%	-$79.4K	﹤0.01%	854
2021 Q4	$72.6K	Buy	1,410 +1,381	+4,762%	+$71.1K	0.02%	461
2021 Q3	$1.43K	Hold	29	–	–	﹤0.01%	807
2021 Q2	$1.66K	Hold	29	–	–	﹤0.01%	811
2021 Q1	$1.76K	Hold	29	–	–	﹤0.01%	671
2020 Q4	$1.55K	Sell	29 -21,237	-100%	-$1.14M	﹤0.01%	632
2020 Q3	$998K	Buy	21,266 +19,812	+1,363%	+$930K	0.29%	75
2020 Q2	$75.9K	Sell	1,454 -46,590	-97%	-$2.43M	0.02%	305
2020 Q1	$2.3M	Sell	48,044 -24,512	-34%	-$1.18M	0.64%	31
2019 Q4	$3.9M	Sell	72,556 -5,487	-7%	-$295K	0.72%	33
2019 Q3	$3.68M	Buy	78,043 +72,326	+1,265%	+$3.41M	0.66%	31
2019 Q2	$269K	Sell	5,717 -72,912	-93%	-$3.43M	0.05%	219
2019 Q1	$3.78M	Buy	78,629 +9,632	+14%	+$464K	0.75%	34
2018 Q4	$3.08M	Buy	68,997 +65,648	+1,960%	+$2.93M	0.55%	49
2018 Q3	$180K	Sell	3,349 -3,040	-48%	-$164K	0.03%	241
2018 Q2	$317K	Buy	6,389 +4,355	+214%	+$216K	0.05%	185
2018 Q1	$126K	Sell	2,034 -11,352	-85%	-$702K	0.03%	262
2017 Q4	$820K	Buy	13,386 +12,455	+1,338%	+$763K	0.14%	108
2017 Q3	$62.3K	Sell	931 -261	-22%	-$17.5K	0.01%	261
2017 Q2	$92.9K	Sell	1,192 -181	-13%	-$14.1K	0.02%	247
2017 Q1	$112K	Sell	1,373 -1,200	-47%	-$97.8K	0.03%	207
2016 Q4	$185K	Sell	2,573 -275	-10%	-$19.8K	0.04%	182
2016 Q3	$221K	Sell	2,848 -584	-17%	-$45.4K	0.03%	181
2016 Q2	$268K	Sell	3,432 -323	-9%	-$25.2K	0.04%	183
2016 Q1	$308K	Sell	3,755 -202,216	-98%	-$16.6M	0.04%	145
2015 Q4	$18.4M	Buy	205,971 +203,097	+7,067%	+$18.1M	2.52%	7
2015 Q3	$221K	Buy	2,874 +2,872	+143,600%	+$221K	0.03%	156
2015 Q2	$167	Hold	2	–	–	﹤0.01%	423
2015 Q1	$181	Sell	2 -154,128	-100%	-$13.9M	﹤0.01%	428
2014 Q4	$12.4M	Buy	+154,130	New	+$12.4M	1.72%	29